Appendix 3B - Proposed issue of securities Update Summary Entity name THE HYDRATION PHARMACEUTICALS COMPANY LIMITED Announcement Type Update to previous announcement Date of this announcement 11/11/2026 Reason for update to a previous announcement Extension to Closing Date of the offer Refer to...
Update - Proposed issue of securities - HPC
Filed with ASX · · 8 pages · English
Summary by 6ix AI
Hydration Pharmaceuticals Company Limited has filed an update regarding a proposed issue of securities, specifically extending the closing date of the offer. This announcement serves as an update to a previous announcement made in late October. The proposed issue is a non-renounceable pro-rata offer of ordinary fully paid shares. The funds raised will primarily support the company's ongoing working capital requirements.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Release
Hydration Pharmaceuticals Company Limited on 6ix
In the deck
Story so far
Earlier from Hydration Pharmaceuticals
- Investor Presentation
- Change of Director's Interest Notice
- Notification of cessation of securities - HPC
- Rights Offer - Despatch of Prospectus
- Q3 FY26 Quarterly Activities Report (App 4C)
Later from Hydration Pharmaceuticals
All Hydration Pharmaceuticals news releasesFollow Hydration Pharmaceuticals into a list and get an email when it puts out news.
Follow Hydration Pharmaceuticals